Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (191-200 of 272) with videos related to

Pageof 28
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformationAnn-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Oncotarget|October 27, 2016
The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanomaLorena P Suarez-Kelly, Gregory M Kemper, Megan C Duggan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2011
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanomaKevin B Kim, Jeffrey A Sosman, John P Fruehauf, et al.
Melanoma Research|May 23, 2019
Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapyMegan C Duggan, Kelly Regan-Fendt, Gonzalo N Olaverria Salavaggione, et al.
Blood|January 10, 2008
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitroAruna Gowda, Julie Roda, Syed-Rehan A Hussain, et al.
Journal for Immunotherapy of Cancer|May 30, 2019
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitroBrooke Benner, Luke Scarberry, Lorena P Suarez-Kelly, et al.
Plos One|June 29, 2023
Expression of microRNAs and their target genes in melanomas originating from gynecologic sitesMallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, et al.
Advanced Healthcare Materials|October 18, 2021
In Situ Deployment of Engineered Extracellular Vesicles into the Tumor Niche via Myeloid-Derived Suppressor CellsSilvia Duarte-Sanmiguel, Ana Panic, Daniel J Dodd, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2017
Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanomaMegan C Duggan, Andrew R Stiff, Maryam Bainazar, et al.
Cancer Research|October 17, 2008
IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosisGregory B Lesinski, Ene T Raig, Kristan Guenterberg, et al.
Pageof 28

Showing results (191-200 of 272) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformationAnn-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Oncotarget|October 27, 2016
The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanomaLorena P Suarez-Kelly, Gregory M Kemper, Megan C Duggan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2011
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanomaKevin B Kim, Jeffrey A Sosman, John P Fruehauf, et al.
Melanoma Research|May 23, 2019
Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapyMegan C Duggan, Kelly Regan-Fendt, Gonzalo N Olaverria Salavaggione, et al.
Blood|January 10, 2008
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitroAruna Gowda, Julie Roda, Syed-Rehan A Hussain, et al.
Journal for Immunotherapy of Cancer|May 30, 2019
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitroBrooke Benner, Luke Scarberry, Lorena P Suarez-Kelly, et al.
Plos One|June 29, 2023
Expression of microRNAs and their target genes in melanomas originating from gynecologic sitesMallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, et al.
Advanced Healthcare Materials|October 18, 2021
In Situ Deployment of Engineered Extracellular Vesicles into the Tumor Niche via Myeloid-Derived Suppressor CellsSilvia Duarte-Sanmiguel, Ana Panic, Daniel J Dodd, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2017
Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanomaMegan C Duggan, Andrew R Stiff, Maryam Bainazar, et al.
Cancer Research|October 17, 2008
IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosisGregory B Lesinski, Ene T Raig, Kristan Guenterberg, et al.
Pageof 28